Follow us on:

GILD

Gilead Sciences, Inc. – Consensus ‘buy’ rating and .1% Upside Potential

September 27, 2024

Gilead Sciences, Inc. Share Price Target ‘$82.29’, now 4.0% Upside Potential

September 6, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 4.7% Upside Potential

August 30, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 8.8% Upside Potential

August 22, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 6.5% Upside Potential

August 2, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 10.2% Upside Potential

July 26, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.93’, now 19.2% Upside Potential

July 12, 2024

Gilead Sciences, Inc. Share Price Target ‘$75.50’, now 13.4% Upside Potential

July 5, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.49’, now 17.6% Upside Potential

June 28, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.21’, now 28.6% Upside Potential

June 21, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.21’, now 29.3% Upside Potential

June 14, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 21.3% Upside Potential

May 17, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 25.2% Upside Potential

May 10, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 19.0% Upside Potential

April 19, 2024

Gilead Sciences, Inc. Share Price Target ‘$78.46’, now 12.8% Upside Potential

April 5, 2024

Gilead Sciences, Inc. Share Price Target ‘$85.04’, now 14.9% Upside Potential

March 22, 2024

Gilead Sciences, Inc. Share Price Target ‘$86.21’, now 18.1% Upside Potential

February 29, 2024

Gilead Sciences, Inc. Share Price Target ‘$79.67’, now 9.5% Upside Potential

February 23, 2024

Gilead Sciences, Inc. Share Price Target ‘$87.04’, now 19.2% Upside Potential

February 16, 2024

Gilead Sciences, Inc. Share Price Target ‘$87.63’, now 17.8% Upside Potential

February 9, 2024

News and Interview Alerts

Company Presentations

SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO

One Health Group (AQSE:OHGR) final results presentation

Cerillion CEO & CFO present stellar H1 2024 interim results

Poolbeg Pharma – Well Positioned for Success with CEO Jeremy Skillington

Q&As

Elemental Royalty Corporation

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

17 December 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video)

Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video)

BrokerTalk

JPMorgan European Discovery Trust plc

JPMorgan European Discovery Trust (JEDT) Latest Research, January 2026

8 January 2026

Pharos Energy

Pharos Energy Strengthens Position in Egypt and Vietnam, Says Cavendish

8 January 2026

Pharos Energy

Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research

18 December 2025

Elemental Royalty Corp.

Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald

18 December 2025

Sintana Energy

Sintana Energy Set to Unlock South Atlantic Potential, Says Auctus Advisors

17 December 2025

Funds

ACG Metals

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights

9 February 2026

Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE

9 February 2026

Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings

9 February 2026

Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance

9 February 2026

Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE

9 February 2026

News

Gilead Sciences, Inc. – Consensus ‘buy’ rating and .1% Upside Potential

September 27, 2024

Gilead Sciences, Inc. Share Price Target ‘$82.29’, now 4.0% Upside Potential

September 6, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 4.7% Upside Potential

August 30, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 8.8% Upside Potential

August 22, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 6.5% Upside Potential

August 2, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 10.2% Upside Potential

July 26, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.93’, now 19.2% Upside Potential

July 12, 2024

Gilead Sciences, Inc. Share Price Target ‘$75.50’, now 13.4% Upside Potential

July 5, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.49’, now 17.6% Upside Potential

June 28, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.21’, now 28.6% Upside Potential

June 21, 2024

Gilead Sciences, Inc. Share Price Target ‘$81.21’, now 29.3% Upside Potential

June 14, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 21.3% Upside Potential

May 17, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 25.2% Upside Potential

May 10, 2024

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 19.0% Upside Potential

April 19, 2024

Gilead Sciences, Inc. Share Price Target ‘$78.46’, now 12.8% Upside Potential

April 5, 2024

Gilead Sciences, Inc. Share Price Target ‘$85.04’, now 14.9% Upside Potential

March 22, 2024

Gilead Sciences, Inc. Share Price Target ‘$86.21’, now 18.1% Upside Potential

February 29, 2024

Gilead Sciences, Inc. Share Price Target ‘$79.67’, now 9.5% Upside Potential

February 23, 2024

Gilead Sciences, Inc. Share Price Target ‘$87.04’, now 19.2% Upside Potential

February 16, 2024

Gilead Sciences, Inc. Share Price Target ‘$87.63’, now 17.8% Upside Potential

February 9, 2024

News and Interview Alerts

Company Presentations

SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO

One Health Group (AQSE:OHGR) final results presentation

Cerillion CEO & CFO present stellar H1 2024 interim results

Poolbeg Pharma – Well Positioned for Success with CEO Jeremy Skillington

Q&As

Elemental Royalty Corporation

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

17 December 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest interviews

Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video)

Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video)

Broker Talk

JPMorgan European Discovery Trust plc

JPMorgan European Discovery Trust (JEDT) Latest Research, January 2026

8 January 2026

Pharos Energy

Pharos Energy Strengthens Position in Egypt and Vietnam, Says Cavendish

8 January 2026

Pharos Energy

Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research

18 December 2025

Elemental Royalty Corp.

Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald

18 December 2025

Sintana Energy

Sintana Energy Set to Unlock South Atlantic Potential, Says Auctus Advisors

17 December 2025

Funds

ACG Metals

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights

9 February 2026

Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE

9 February 2026

Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings

9 February 2026

Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance

9 February 2026

Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE

9 February 2026

GILD

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and .1% Upside Potential

27 September 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$82.29’, now 4.0% Upside Potential

6 September 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 4.7% Upside Potential

30 August 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 8.8% Upside Potential

22 August 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 6.5% Upside Potential

2 August 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 10.2% Upside Potential

26 July 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$81.93’, now 19.2% Upside Potential

12 July 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$75.50’, now 13.4% Upside Potential

5 July 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$81.49’, now 17.6% Upside Potential

28 June 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$81.21’, now 28.6% Upside Potential

21 June 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$81.21’, now 29.3% Upside Potential

14 June 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 21.3% Upside Potential

17 May 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 25.2% Upside Potential

10 May 2024

Broker Ratings

Gilead Sciences, Inc. – Consensus ‘buy’ rating and 19.0% Upside Potential

19 April 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$78.46’, now 12.8% Upside Potential

5 April 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$85.04’, now 14.9% Upside Potential

22 March 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$86.21’, now 18.1% Upside Potential

29 February 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$79.67’, now 9.5% Upside Potential

23 February 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$87.04’, now 19.2% Upside Potential

16 February 2024

Broker Ratings

Gilead Sciences, Inc. Share Price Target ‘$87.63’, now 17.8% Upside Potential

9 February 2024

Latest Interviews

Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)

17 December 2025

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

12 December 2025

Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video)

11 December 2025

Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video)

10 December 2025

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Company Presentations

SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO

27 June 2024

One Health Group (AQSE:OHGR) final results presentation

25 June 2024

Cerillion CEO & CFO present stellar H1 2024 interim results

30 May 2024

Poolbeg Pharma – Well Positioned for Success with CEO Jeremy Skillington

20 May 2024

Q&As

Elemental Royalty Corporation

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

17 December 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

BrokerTalk

JPMorgan European Discovery Trust plc

JPMorgan European Discovery Trust (JEDT) Latest Research, January 2026

8 January 2026

Pharos Energy

Pharos Energy Strengthens Position in Egypt and Vietnam, Says Cavendish

8 January 2026

Pharos Energy

Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research

18 December 2025

Elemental Royalty Corp.

Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald

18 December 2025

Sintana Energy

Sintana Energy Set to Unlock South Atlantic Potential, Says Auctus Advisors

17 December 2025

FTSE 100

Funds

ACG Metals

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

View all Funds, Market Insights and news >>

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

UK Broker Ratings

Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights

9 February 2026

Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE

9 February 2026

Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings

9 February 2026

Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance

9 February 2026

Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE

9 February 2026